{
  "id": 9575658,
  "title": "Sarepta to pay Regenxbio $39M to settle gene therapy claims; Vida eyes fourth fund",
  "url": "https://urgent.news/2026/09/24/sarepta-to-pay-regenxbio-39m-to-settle-gene-therapy-claims-vida-eyes",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T15:05:48.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/sarepta-to-pay-regenxbio-39m-to-settle-gene-therapy-claims-vida-eyes-4th-fund/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Frazier Life Sciences, BigHat Biosciences, Kasvu Therapeutics, Arcturus Therapeutics, Oruka Therapeutics and Viking Therapeutics. Sarepta Therapeutics settles gene therapy suit: Sarepta has agreed to pay Regenxbio $39 million to",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}